{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:34:30Z","timestamp":1780608870989,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.cllc.2016.11.011","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T20:51:45Z","timestamp":1481316705000},"page":"504-511.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["High Frequency of Programmed Death-ligand 1\u00a0Expression in Emphysematous Bullae-associated Lung Adenocarcinomas"],"prefix":"10.1016","volume":"18","author":[{"given":"Gouji","family":"Toyokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kozuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Haratake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinkichi","family":"Takamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Akamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2016.11.011_bib1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/JTO.0b013e3181e452b9","article-title":"Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002","volume":"5","author":"Sawabata","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.11.011_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2016.11.011_bib3","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2016.11.011_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2016.11.011_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1378\/chest.23.4.403","article-title":"The correlation of carcinoma and congenital cystic emphysema of the lungs; report of ten cases","volume":"23","author":"Korol","year":"1953","journal-title":"Dis Chest"},{"key":"10.1016\/j.cllc.2016.11.011_bib6","first-page":"1062","article-title":"Bronchogenic carcinoma and giant bullous disease","volume":"97","author":"Goldstein","year":"1968","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.cllc.2016.11.011_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/00039896.1971.10665827","article-title":"The risk of lung cancer in males with bullous disease of the lung","volume":"22","author":"Stoloff","year":"1971","journal-title":"Arch Environ Health"},{"key":"10.1016\/j.cllc.2016.11.011_bib8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0003-4975(10)64733-9","article-title":"Characteristic radiographic features of pulmonary carcinoma associated with large bulla","volume":"46","author":"Tsutsui","year":"1988","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2016.11.011_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0022-5223(19)33764-X","article-title":"Bullae and lung cancer","volume":"106","author":"Nickoladze","year":"1993","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2016.11.011_bib10","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jtho.2016.04.024","article-title":"Characteristics of smoking patients with lung cancer with emphysematous bullae","volume":"11","author":"Iwama","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.11.011_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0169-5002(02)00186-1","article-title":"Primary lung carcinoma arising from emphysematous bullae","volume":"38","author":"Hanaoka","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2016.11.011_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1289\/ehp.8564111","article-title":"Free-radical chemistry of cigarette smoke and its toxicological implications","volume":"64","author":"Church","year":"1985","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.cllc.2016.11.011_bib13","first-page":"252","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat\u00a0Rev Cancer"},{"key":"10.1016\/j.cllc.2016.11.011_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cllc.2016.11.011_bib15","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jtho.2016.06.006","article-title":"Clinical significance of PD-L1 protein expression in surgically resected primary lung adenocarcinoma","volume":"11","author":"Takada","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.11.011_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cllc.2016.11.011_bib17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MCP.0000000000000217","article-title":"Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update","volume":"21","author":"Antoniou","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.cllc.2016.11.011_bib18","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1158\/1078-0432.CCR-13-2683","article-title":"Prognostic and therapeutic implications of aromatase expression in lung adenocarcinomas with EGFR mutations","volume":"20","author":"Kohno","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2016.11.011_bib19","first-page":"3409","article-title":"An immunohistochemical analysis of PD-L1 protein expression in surgically resected small cell lung cancer using different antibodies and criteria","volume":"36","author":"Takada","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cllc.2016.11.011_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cllc.2016.11.011_bib21","first-page":"1935","article-title":"Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer","volume":"25","author":"Azuma","year":"2014","journal-title":"Ann\u00a0Oncol"},{"key":"10.1016\/j.cllc.2016.11.011_bib22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jtho.2016.04.007","article-title":"Prognostic significance of programmed cell death ligand 1 in patients with non-small-cell lung cancer: a large cohort study of surgically resected cases","volume":"11","author":"Sun","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.11.011_bib23","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S1470-2045(15)00307-1","article-title":"PD-L1 expression as a potential predictive biomarker","volume":"16","author":"Fusi","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2016.11.011_bib24","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2016.11.011_bib25","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00330-015-3601-y","article-title":"Rapid needle-out patient-rollover approach after cone beam CT-guided lung biopsy: effect on pneumothorax rate in 1,191 consecutive patients","volume":"25","author":"Kim","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cllc.2016.11.011_bib26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/1744666X.2013.828875","article-title":"Immune response in chronic obstructive pulmonary disease","volume":"9","author":"Faner","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.cllc.2016.11.011_bib27","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/0008-5472.CAN-03-3259","article-title":"PD-L1\/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells","volume":"64","author":"Blank","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2016.11.011_bib28","doi-asserted-by":"crossref","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cllc.2016.11.011_bib29","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/bjc.2015.101","article-title":"IFN-gamma from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer","volume":"112","author":"Abiko","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2016.11.011_bib30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1158\/2159-8290.CD-RW2016-051","article-title":"MYC promotes tumorigenesis via activation of CD47 and PD-L1","volume":"6","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.cllc.2016.11.011_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730416303655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730416303655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:06:24Z","timestamp":1761505584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730416303655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1525730416303655"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2016.11.011","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Frequency of Programmed Death-ligand 1\u00a0Expression in Emphysematous Bullae-associated Lung Adenocarcinomas","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2016.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}